| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0005 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.004 |